Meet the Team

pH Blueprint pairs clients with a team who possess precisely the experience and expertise needed to pinpoint and understand the nature of the opportunities or challenges our clients face

We leverage decades of domain expertise to approach our engagements pragmatically and open-mindedly and excel at engagements that require analytical rigor against tight timeframes

Rachel Ravens

Co-Founder and Managing Partner

Rachel manages strategic consulting at pH Blueprint, building and transforming global health care companies by focusing on elevating the experience for patients, providers, payers, and partners.

Rachel has 18 years of experience in the Healthcare and Life Sciences sectors. With a background in biomedical engineering and business, she has dedicated her career to bridging healthcare fractions. She has worked with leading academic institutions, health systems, devices, and diagnostic companies to develop strategic relationships, market analysis, reimbursement strategy, product development, and commercial execution.

She was appointed Adjunct Professor at Northwestern Feinberg Medical School and continues to collaborate with her alma mater Columbia University. Prior to pH Blueprint, Rachel ran strategy for diagnostic companies, both domestic and international.

Erik Halvorsen – PhD

Partner

Erik is a Partner at pH Blueprint with 20 years of experience in the Healthcare and Life Sciences sectors as an entrepreneur, investor, founder, operator, and board member.  With a Ph.D. in neuropharmacology and experience in regenerative medicine, drug development, clinical trials, digital health, and medical devices, Erik brings a broad range of knowledge and deep network to his clients.

 Erik has worked with numerous leading academic institutions, medical centers, VCs, disease foundations, pharma, device, and diagnostic companies on a range of financing, M&A, strategic partnership, and licensing transactions. 

As an entrepreneur, Erik has raised millions of dollars and founded/co-founded several companies including therapeutics, clinical genomics, robotics, diagnostics, and AI-focused digital health with a couple of exits to show for it—and hopefully a couple more on the way.  He also launched and ran early-stage life science investment funds in Boston and Houston. Erik has a personal passion for finding better treatments for pediatric diseases and cancers.  

When taking a break from work Erik likes to catch a Chicago Bears game or watch UVA basketball, his alma mater. 

Bridget Dickinson

Analyst

Bridget is an analyst at pH Blueprint focused on providing strategic advisory services for clients in the Healthcare and Life Sciences sectors. Bridget graduated from the University of Texas with a bachelor’s in Public Health and a Master’s in Design in Health. Bridget gained expertise in human-centered design methodologies that wield new approaches to solve some of the most challenging problems in health.

She applies systemic design methods to frame a problem, understand a system, and identify opportunities for design impact and intervention to drive innovation in healthcare. 

Prior to pH Blueprint, she worked with private medical practices, retail clinic services, and research institutions to reshape our healthcare system to better understand and advocate for the needs of all patients.  

Rahul Rathod – MD

Senior Medical Advisor

Rahul Rathod, MD is the Director of Operations and Strategy at Boston Children’s Hospital and is an Associate Professor at Harvard Medical School. Dr. Rathod received his M.D. from Case Western Reserve University School of Medicine. He completed his pediatric residency at Rainbow Babies and Children’s Hospital and his cardiology and advanced imaging fellowship at Boston Children’s Hospital. He is anticipated to receive his M.B.A. from the Massachusetts Institute of Technology in May of 2022.

Dr. Rathod possesses over 20 years of experience in healthcare operations, medical technology, and program development. He is an experienced entrepreneur and intrapreneur, identifying systems issues and building tech-enabled solutions that increase efficiency organization-wide. Dr. Rathod has authored over 60+ publications and is an internationally recognized key opinion leader and medical expert. Previously, he founded and served as the Chief Executive Officer at NextMed Technologies, a medical technology company improving physician communication and handoff software solutions for hospital systems, residency programs, and physician groups. Dr. Rathod is known for his unique ability to leverage clinical, operational, and IT experience for unique and executable solutions to real-world problems.

Animesh Tandon – MD

Senior Medical Advisor

Animesh (Aashoo), MD, MS, is an Assistant Professor of Pediatrics, with a joint appointment in Radiology, and faculty in Biomedical Engineering, at UT Southwestern. He graduated from Washington University in St. Louis with a BA in 2003. During his medical training at the University of Michigan Medical School, he performed a research fellowship at the NINDS/NIH through the Howard Hughes Medical Institute/NIH Research Scholars (Cloister) Program. Dr. Tandon completed his pediatric residency and categorical pediatric cardiology fellowship at Cincinnati Children’s Hospital Medical Center. During his fellowship, he earned a Master’s in Clinical and Translational Research from the University of Cincinnati. He then completed an advanced imaging fellowship at Children’s Healthcare of Atlanta/Emory University.

His current clinical and research interests are focused on the use of cardiac MRI (CMR) in congenital heart disease; the development and use of wearable biosensors and other monitoring devices; the collection and analysis of big data through machine learning and the development of predictive analytics; 3D printing, 3D visualization, virtual reality, and augmented reality in congenital heart disease; and fellow education. He is especially passionate about bringing technology to children’s medical needs.

He is heavily involved in innovation and mentorship at a national level. He has leadership roles in the American Heart Association Center for Health Technology & Innovation (CHTI) Health Technology Advisory Group (HTAG); the American Academy of Pediatrics; the Society of Cardiovascular Magnetic Resonance; and previously at the American College of Cardiology.

Ashok Gowda – PhD

Medical Device Advisor

Dr. Gowda is the founder and CEO of the Houston-based medical technology developer and manufacturer, Biotex, Inc. To date, under his direction, the company has raised over $25M in non-dilutive funding, successfully licensed numerous early-stage technologies, spun out three separate companies (Visualase, Inc., Base Pair Biotechnologies, Inc., E-SAFE Medical, Inc.), incubated multiple medical device startups, and most recently launched an early-stage medical device fund. Dr. Gowda oversees development programs as well as partnering activities, where the company works with physicians, entrepreneurs, and start-ups to develop and bring to market their new medical device ideas. Previously, Dr. Gowda co-founded and served as President, and Chief Operating Officer at Visualase, Inc., which was acquired by Medtronic for $100M in 2014.

Dr. Gowda is an active investor, advisor, and board member for a number of early-stage medical technology companies. Dr. Gowda has served as principal investigator on more than 15 NIH grants, authored more than 50 peer-reviewed publications and abstracts, and is an inventor on more than 25 issued patents. Dr. Gowda received his Bachelor of Engineering degree in Biomedical Engineering from Vanderbilt University and the M.S. and Ph.D. degrees in Bioengineering from Texas A&M University.

Kevin Coker – JD, MPH

Regulatory Advisor

Kevin is a Co-Founder and the Chief Executive Officer at Proxima, the fastest growing CRO serving life science technology companies. He has 20+ years of experience in the healthcare industry.  He has been the founder, board member, and executive at many life science companies: Worldwide Clinical Trials, McKesson Corporation, and US Oncology.

Kevin is an attorney and is certified in regulatory affairs. He has worked with hundreds of pharmaceutical, biotech, and life science companies.

Rachel Ravens

Co-Founder and Managing Partner  

Rachel manages strategic consulting at pH Blueprint, building and transforming global health care companies by focusing on elevating the experience for patients, providers, payers, and partners.

Rachel has 18 years of experience in the Healthcare and Life Sciences sectors. With a background in biomedical engineering and business, she has dedicated her career to bridging healthcare fractions. She has worked with leading academic institutions, health systems, devices, and diagnostic companies to develop strategic relationships, market analysis, reimbursement strategy, product development, and commercial execution.

She was appointed Adjunct Professor at Northwestern Feinberg Medical School and continues to collaborate with her alma mater Columbia University. Prior to pH Blueprint, Rachel ran strategy for diagnostic companies, both domestic and international.

Erik Halvorsen – PhD

Partner

Erik is a Partner at pH Blueprint with 20 years of experience in the Healthcare and Life Sciences sectors as an entrepreneur, investor, founder, operator, and board member.  With a Ph.D. in neuropharmacology and experience in regenerative medicine, drug development, clinical trials, digital health, and medical devices, Erik brings a broad range of knowledge and deep network to his clients.

Erik has worked with numerous leading academic institutions, medical centers, VCs, disease foundations, pharma, device, and diagnostic companies on a range of financing, M&A, strategic partnership, and licensing transactions.

As an entrepreneur, Erik has raised millions of dollars and founded/co-founded several companies including therapeutics, clinical genomics, robotics, diagnostics, and AI-focused digital health with a couple of exits to show for it—and hopefully a couple more on the way.  He also launched and ran early-stage life science investment funds in Boston and Houston. Erik has a personal passion for finding better treatments for pediatric diseases and cancers.

When taking a break from work Erik likes to catch a Chicago Bears game or watch UVA basketball, his alma mater.

Bridget Dickinson

Analyst

Bridget is an analyst at pH Blueprint focused on providing strategic advisory services for clients in the Healthcare and Life Sciences sectors. Bridget graduated from the University of Texas with a bachelor’s in Public Health and a Master’s in Design in Health. Bridget gained expertise in human-centered design methodologies that wield new approaches to solve some of the most challenging problems in health.

She applies systemic design methods to frame a problem, understand a system, and identify opportunities for design impact and intervention to drive innovation in healthcare. 

Prior to pH Blueprint, she worked with private medical practices, retail clinic services, and research institutions to reshape our healthcare system to better understand and advocate for the needs of all patients.  

Rahul Rathod – MD

Senior Medical Advisor

Rahul Rathod, MD is the Director of Operations and Strategy at Boston Children’s Hospital and is an Associate Professor at Harvard Medical School. Dr. Rathod received his M.D. from Case Western Reserve University School of Medicine. He completed his pediatric residency at Rainbow Babies and Children’s Hospital and his cardiology and advanced imaging fellowship at Boston Children’s Hospital. He is anticipated to receive his M.B.A. from the Massachusetts Institute of Technology in May of 2022.

Dr. Rathod possesses over 20 years of experience in healthcare operations, medical technology, and program development. He is an experienced entrepreneur and intrapreneur, identifying systems issues and building tech-enabled solutions that increase efficiency organization-wide. Dr. Rathod has authored over 60+ publications and is an internationally recognized key opinion leader and medical expert. Previously, he founded and served as the Chief Executive Officer at NextMed Technologies, a medical technology company improving physician communication and handoff software solutions for hospital systems, residency programs, and physician groups. Dr. Rathod is known for his unique ability to leverage clinical, operational, and IT experience for unique and executable solutions to real-world problems.

Animesh Tandon – MD

Senior Medical Advisor

Animesh (Aashoo) Tandon, MD, MS, is an Assistant Professor of Pediatrics, with a joint appointment in Radiology, and faculty in Biomedical Engineering, at UT Southwestern. He graduated from Washington University in St. Louis with a BA in 2003. During his medical training at the University of Michigan Medical School, he performed a research fellowship at the NINDS/NIH through the Howard Hughes Medical Institute/NIH Research Scholars (Cloister) Program. Dr. Tandon completed his pediatric residency and categorical pediatric cardiology fellowship at Cincinnati Children’s Hospital Medical Center. During his fellowship, he earned a Master’s in Clinical and Translational Research from the University of Cincinnati. He then completed an advanced imaging fellowship at Children’s Healthcare of Atlanta/Emory University.

His current clinical and research interests are focused on the use of cardiac MRI (CMR) in congenital heart disease; the development and use of wearable biosensors and other monitoring devices; the collection and analysis of big data through machine learning and the development of predictive analytics; 3D printing, 3D visualization, virtual reality, and augmented reality in congenital heart disease; and fellow education. He is especially passionate about bringing technology to children’s medical needs.

He is heavily involved in innovation and mentorship at a national level. He has leadership roles in the American Heart Association Center for Health Technology & Innovation (CHTI) Health Technology Advisory Group (HTAG); the American Academy of Pediatrics; the Society of Cardiovascular Magnetic Resonance; and previously at the American College of Cardiology.

Ashok Gowda – PhD

Medical Device Advisor

Dr. Gowda is the founder and CEO of the Houston-based medical technology developer and manufacturer, Biotex, Inc. To date, under his direction, the company has raised over $25M in non-dilutive funding, successfully licensed numerous early-stage technologies, spun out three separate companies (Visualase, Inc., Base Pair Biotechnologies, Inc., E-SAFE Medical, Inc.), incubated multiple medical device startups, and most recently launched an early-stage medical device fund. Dr. Gowda oversees development programs as well as partnering activities, where the company works with physicians, entrepreneurs, and start-ups to develop and bring to market their new medical device ideas. Previously, Dr. Gowda co-founded and served as President, and Chief Operating Officer at Visualase, Inc., which was acquired by Medtronic for $100M in 2014.

Dr. Gowda is an active investor, advisor, and board member for a number of early-stage medical technology companies. Dr. Gowda has served as principal investigator on more than 15 NIH grants, authored more than 50 peer-reviewed publications and abstracts, and is an inventor on more than 25 issued patents. Dr. Gowda received his Bachelor of Engineering degree in Biomedical Engineering from Vanderbilt University and the M.S. and Ph.D. degrees in Bioengineering from Texas A&M University.

Evelyn Nordin

Financial Strategist 

Evelyn provides financial and operational planning services for pH Blueprint clients, complementing the product and technical advisory provided by the rest of the team.  Evelyn develops the “financial story” that must accompany the “innovation story” for healthcare companies looking to grow.

Evelyn has over 20 years helping companies develop financial strategy and infrastructure; navigate debt and equity capital markets; and effectively communicate with external stakeholders.

She has gravitated toward challenging roles that require both technical and strategic expertise to help companies operate in volatile or emerging industries.  She spent a decade in IT, over a decade in oilfield services, and more recently has extended into biotech.

Kevin Coker – JD, MPH

Regulatory Advisor

Kevin is a Co-Founder and the Chief Executive Officer at Proxima, the fastest growing CRO serving life science technology companies. He has 20+ years of experience in the healthcare industry. He has been the founder, board member, and executive at many life science companies: Worldwide Clinical Trials, McKesson Corporation, and US Oncology.

Kevin is an attorney and is certified in regulatory affairs. He has worked with hundreds of pharmaceutical, biotech, and life science companies.

Austin, TX | New York, NY

info@phblueprint.com
2208 Lake Austin Boulevard | 1st Floor
Austin, TX 78703